Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    plecanatide
Show Display Options
Rank Status Study
1 Completed Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Condition: Chronic Idiopathic Constipation
Intervention: Drug: Plecanatide
2 Completed 12-Week Study of Plecanatide for CIC (The CIC3 Study)
Condition: Chronic Idiopathic Constipation
Interventions: Drug: Plecanatide;   Drug: Placebo
3 Completed 12-Week Study of Plecanatide for CIC (The National CIC3 Study)
Condition: Chronic Idiopathic Constipation
Interventions: Drug: Plecanatide;   Drug: Placebo
4 Completed The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Condition: Chronic Idiopathic Constipation
Intervention: Drug: plecanatide
5 Recruiting Long Term Safety Study of Plecanatide
Condition: Irritable Bowel Syndrome
Intervention: Drug: Plecanatide
6 Recruiting The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Condition: Irritable Bowel Syndrome Characterized by Constipation
Interventions: Drug: Plecanatide;   Drug: Placebo
7 Recruiting Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Condition: Irritable Bowel Syndrome Characterized by Constipation
Interventions: Drug: Plecanatide;   Drug: Placebo
8 Completed The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Condition: Irritable Bowel Syndrome Characterized by Constipation
Interventions: Drug: Plecanatide;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.